Clinical Trials Directory

Trials / Completed

CompletedNCT01975649

Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Federal University of Minas Gerais · Academic / Other
Sex
Female
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Hypoactive Sexual Desire Disorder ( HSDD ) is very common in postmenopausal women due to a reduction in circulating androgen levels. The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD.

Detailed description

Hypoactive Sexual Desire Disorder ( HSDD ) is the most prevalent female sexual dysfunction in society mainly in postmenopausal women, and is strongly linked to the quality of life of women . The androgen hormones decline over age in the premenopausal period, more sharply after menopause. Tribulus terrestris is a plant native to India , recommended in the treatment of infertility , low libido and impotence . Its main active ingredient is the protodioscin , which has been attributed to an increase in testosterone levels and improved sexual function . The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD .

Conditions

Interventions

TypeNameDescription
DRUGTribulus Terrestrispatients will use 750 mg/day during 120 days
OTHERPlacebopatients will use placebo pills with the same shape of the drug

Timeline

Start date
2013-06-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2013-11-05
Last updated
2015-04-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01975649. Inclusion in this directory is not an endorsement.